157 related articles for article (PubMed ID: 33686374)
1. Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic.
Yeboa DN; Akinfenwa CA; Nguyen J; Amaya D; de Gracia B; Ning M; Cox V; De B; Smith BD; Lin L; Beddar S; Hoang H; Koong A; Liao Z
Adv Radiat Oncol; 2021; 6(3):100676. PubMed ID: 33686374
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
3. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
[TBL] [Abstract][Full Text] [Related]
4. Oncology clinical trial disruption during the COVID-19 pandemic: a COVID-19 and cancer outcomes study.
Bakouny Z; Labaki C; Bhalla S; Schmidt AL; Steinharter JA; Cocco J; Tremblay DA; Awad MM; Kessler A; Haddad RI; Evans M; Busser F; Wotman M; Curran CR; Zimmerman BS; Bouchard G; Jun T; Nuzzo PV; Qin Q; Hirsch L; Feld J; Kelleher KM; Seidman D; Huang H; Anderson-Keightly HM; El Zarif T; Alaiwi SA; Champagne C; Rosenbloom TD; Stewart PS; Johnson BE; Trinh Q; Tolaney SM; Galsky MD; Choueiri TK; Doroshow DB
Ann Oncol; 2022 Aug; 33(8):836-844. PubMed ID: 35715285
[TBL] [Abstract][Full Text] [Related]
5. The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.
Ndumele A; Park KU
Curr Breast Cancer Rep; 2021; 13(3):103-109. PubMed ID: 33995839
[TBL] [Abstract][Full Text] [Related]
6. Creating and Implementing a Principal Investigator Tool Kit for Enhancing Accrual to Late Phase Clinical Trials: Development and Usability Study.
Higgins KA; Thomas A; Soto N; Paulus R; George TJ; Julian TB; Hartson Stine S; Markham MJ; Werner-Wasik M
JMIR Cancer; 2022 Aug; 8(3):e38514. PubMed ID: 36006678
[TBL] [Abstract][Full Text] [Related]
7. International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials.
Smeltzer MP; Scagliotti GV; Wakelee HA; Mitsudomi T; Roy UB; Clark RC; Arndt R; Pruett CD; Kelly KL; Ujhazy P; Johnson ML; Eralp Y; Barrios CH; Barlesi F; Hirsch FR; Bunn PA;
J Thorac Oncol; 2022 May; 17(5):651-660. PubMed ID: 35183774
[TBL] [Abstract][Full Text] [Related]
8. Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology.
Agostinelli V; Ballatore Z; Ricci G; Lucarelli A; Burattini M; Mariotti L; Catani C; Tarantino V; Berardi R
Explor Target Antitumor Ther; 2023; 4(5):1095-1103. PubMed ID: 38023994
[TBL] [Abstract][Full Text] [Related]
9. Implementation of Single-Fraction Lung Stereotactic Ablative Radiotherapy in a Multicenter Provincial Cancer Program During the COVID-19 Pandemic.
Mou B; Hyde D; Araujo C; Bartha L; Bergman A; Liu M
Cureus; 2021 Jun; 13(6):e15598. PubMed ID: 34277219
[TBL] [Abstract][Full Text] [Related]
10. Meeting the challenges of retention and enrollment of study participants in clinical trials during the COVID-19 pandemic from the study leadership perspective: Experience from the Zoster Eye Disease Study (ZEDS).
Tom M; Cohen EJ; LopezJimenez C; Hochman JS; Troxel AB; Jeng BH
Contemp Clin Trials Commun; 2021 Dec; 24():100875. PubMed ID: 34805615
[TBL] [Abstract][Full Text] [Related]
11. The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer Centers.
Sundquist S; Kato D; Xu RY; Schoales J; Kulendran S; Dancey JE
Curr Oncol; 2022 Mar; 29(4):2435-2441. PubMed ID: 35448171
[TBL] [Abstract][Full Text] [Related]
12. The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.
Tolaney SM; Lydon CA; Li T; Dai J; Standring A; Legor KA; Caparrotta CM; Schenker MP; Glazer DI; Tayob N; DuBois SG; Meyerhardt JA; Taplin ME; Johnson BE
J Natl Cancer Inst; 2021 Nov; 113(11):1453-1459. PubMed ID: 32959883
[TBL] [Abstract][Full Text] [Related]
13. Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.
Jacobs SR; Weiner BJ; Minasian LM; Good MJ
Contemp Clin Trials; 2013 Mar; 34(2):320-5. PubMed ID: 23295315
[TBL] [Abstract][Full Text] [Related]
14. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 pandemic and impact on cancer clinical trials: An academic medical center perspective.
Marcum M; Kurtzweil N; Vollmer C; Schmid L; Vollmer A; Kastl A; Acker K; Gulati S; Grover P; Herzog TJ; Ahmad SA; Sohal D; Wise-Draper TM
Cancer Med; 2020 Sep; 9(17):6141-6146. PubMed ID: 32648667
[TBL] [Abstract][Full Text] [Related]
16. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
17. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis.
Mesko S; Ning MS; Lakomy D; Verma V; Chang JY; O'Reilly M; Jeter MD; Gandhi SJ; Lin SH; Nguyen QN; Liao Z; Welsh J; Chen AB; Hahn S; Gomez DR
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):897-908. PubMed ID: 32360653
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial enrollment at a rural satellite hospital during COVID-19 pandemic.
Sedhai YR; Sears M; Vecchiè A; Bonaventura A; Greer J; Spence K; Tackett H; Turner J; Pak M; Patel N; Black M; Wohlford G; Clary RE; Duke C; Hardin M; Kemp H; Priday A; Sims EK; Mihalick V; Ho AC; Ibe I; Harmon M; Markley R; Van Tassell B; Abbate A
J Clin Transl Sci; 2021; 5(1):e136. PubMed ID: 34367680
[TBL] [Abstract][Full Text] [Related]
19. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
Jeon J; Kim H; Yu KS
J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
[TBL] [Abstract][Full Text] [Related]
20. The COVID-19 pandemic and new clinical trial activations.
Unger JM; Xiao H
Trials; 2021 Apr; 22(1):260. PubMed ID: 33832534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
